MD1662F1 - Transplant and method of nasal lobe remodelling - Google Patents

Transplant and method of nasal lobe remodelling

Info

Publication number
MD1662F1
MD1662F1 MD20000010A MD20000010A MD1662F1 MD 1662 F1 MD1662 F1 MD 1662F1 MD 20000010 A MD20000010 A MD 20000010A MD 20000010 A MD20000010 A MD 20000010A MD 1662 F1 MD1662 F1 MD 1662F1
Authority
MD
Moldova
Prior art keywords
nasal
transplant
lobe
remodelling
cuneiform
Prior art date
Application number
MD20000010A
Other languages
Romanian (ro)
Inventor
Boris Topor
Ion Ababii
Mihai Maniuc
Sergiu Vertician
Nicolae Buracovschi
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MD20000010A priority Critical patent/MD1662F1/en
Publication of MD1662F1 publication Critical patent/MD1662F1/en

Links

Landscapes

  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

The invention refers to medicine and namely to otorhinolaryngology. Summary of the invention consists in, that the transplant for nasal lobe remodelling is executed in the form of osteomatrix forte plate. The transplant lower part is executed cuneiform and on the fore part it is made a section forming a bulge.It is also claimed a method of nasal lobe remodeling comprising denudation of the nasal septum cartilage, execution of a groove in the nasal crest fore part of the maxilla, formation of a cavity in the nasal lobe tissues. Thereafter the cuneiform transplant part is installed into the groove, and the bulge thereof is placed into the formed cavity.Claims: 3Fig.: 3
MD20000010A 1999-12-29 1999-12-29 Transplant and method of nasal lobe remodelling MD1662F1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD20000010A MD1662F1 (en) 1999-12-29 1999-12-29 Transplant and method of nasal lobe remodelling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD20000010A MD1662F1 (en) 1999-12-29 1999-12-29 Transplant and method of nasal lobe remodelling

Publications (1)

Publication Number Publication Date
MD1662F1 true MD1662F1 (en) 2001-05-31

Family

ID=19739519

Family Applications (1)

Application Number Title Priority Date Filing Date
MD20000010A MD1662F1 (en) 1999-12-29 1999-12-29 Transplant and method of nasal lobe remodelling

Country Status (1)

Country Link
MD (1) MD1662F1 (en)

Similar Documents

Publication Publication Date Title
DE60233806D1 (en) TAMPONEINFÜHRHÜLSE
ATE498359T1 (en) SURGICAL DEVICES
TW200505900A (en) Muscarinic agonists
ATE381299T1 (en) IMPLANT SYSTEM
ES2191536A1 (en) Collagen tubes for nerve regeneration
PT831910E (en) COMBINATION THERAPY BASED ON AN EPOXY-ESTEROIDAL ALDOSTERONE ANTAGONIST AND AN ANGIOTENSIN II ANTAGONIST FOR THE TREATMENT OF CONGESTIVE HEART ATTACK
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
EP1773218A4 (en) Bone plate
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
TW200626131A (en) C-aryl glucoside SGLT2 inhibitors and method
GB2387696A (en) Real-time odds-based gaming
ATE524125T1 (en) PLATE AND SCREWS FOR TREATING BONE FRACTURES
NO331024B1 (en) Use of risendronic acid for the prevention or treatment of osteoporosis
ZA200100607B (en) Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors.
BR0307522A (en) Use of a lipoxygenase-15 inhibitor for the manufacture of a medicament, methods for treatment and prevention, and kit for diagnosing predisposition to bone loss.
BR9913705A (en) Methods for the treatment of multiple myeloma and bone tissue resorption induced by myeloma using integrin antagonists
ATE239474T1 (en) USES OF LEVOBUPIVACAIN
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
HK1041647A1 (en) Utilization of inhibitors of the kqti channel in order to produce a medicament for treating diseaseswhich are caused by parasitic helminths and ecto parasites.
PL350917A1 (en) C16 unsaturated fp-selective prostaglandins analogs
TR200002203T2 (en) Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway.
MD1662F1 (en) Transplant and method of nasal lobe remodelling
MD1662G2 (en) Transplant and method of nasal lobe remodelling
WO2000012047A3 (en) Enhancement of return to independent living status with a growth hormone secretagogue
DK1152757T3 (en) MMP inhibitors in connective tissue softness